Skip to Main Content

Gillian Griffiths, FRS

Anthony N. Brady Professor of Cell Biology; Chair of Cell Biology
DownloadHi-Res Photo

About

Titles

Anthony N. Brady Professor of Cell Biology; Chair of Cell Biology

Biography

Professor Gillian Griffiths obtained her PhD at the MRC Laboratory of Molecular Biology with Cesar Milstein. After a post-doctoral fellowship at Stanford University, she started her own research laboratory at the Basel Institute for Immunology in Switzerland in 1990. She subsequently held posts at University College London, the Dunn School of Pathology, Oxford (1997-2007) before moving to the Cambridge Institute for Medical Research where she was Director 2102-2017. She was elected as a Fellow of the Academy of Medical Sciences (2005); EMBO (2006), and the Royal Society (2013). She was awarded the Royal Society Buchanan medal (2019) in recognition of her ground-breaking research establishing the fundamental cell biological mechanisms that drive CTL killing, laying the foundations for the development of targeted cancer immunotherapy.


Last Updated on July 30, 2025.

Appointments

Other Departments & Organizations

Education & Training

Postdoctoral Fellowship
Stanford University
PhD
University of Cambridge, MRC Laboratory of Molecular Biology (1984)
BSc (Hon)
University College London, Zoology (1980)

Research

Overview

Cytotoxic T lymphocytes (CTLs) play a critical role in the immune system, recognizing and destroying virally infected cells and cancer targets with remarkable specificity. These cells are extraordinarily efficient serial killers that rapidly deliver their lethal hit using precisely polarized secretion of cytolytic proteins from modified lysosomes to destroy their targets. CTLs provide a fascinating system in which to understand the cell biology of secretion in a specialized cell type. This is particularly important right now, with new immunotherapies focused on harnessing the cytotoxic potential of these cells to combat cancer.

CTLs form a highly dynamic immune synapse with their targets and killing is accomplished in minutes. One reason that CTLs are so effective is because they are serial killers, killing one target after another.

Using a combination of genetics, transcriptomics, biochemistry and high-resolution microscopy our research has shown how organelles including the centrosome, specialized secretory lysosomes, mitochondria and dynamic membrane changes are coordinated in response to signal strength. We have made important conceptual advances, revealing parallels between the immune synapse and cilia, demonstrating roles for common molecular pathways including Hedgehog signaling and membrane specialization. Using scRNAseq we showed that T cell receptor (TCR) signal strength controls how rapidly and simultaneously naïve T cells initiate activation, demonstrating how finite signaling machinery can further extend the range of responses generated in an immune response. We also uncovered a novel role for mitochondrial translation in controlling sustained, serial killing.

More recently we showed that activated TCRs are shed by ectocytosis (outward budding) at the immune synapse rather than endocytosis (internalization) as previously thought. Ectocytosis simultaneously removes activated TCRs and initiates cell separation, seamlessly linking TCR activation with down-regulation and CTL release. Our findings suggest a model of ectosome formation that is likely to apply to many other biological systems in which outward budding vesicles are generated during receptor signaling.

Our current research is focused on using multispectral and high-resolution imaging to follow the rapid reorganization of intracellular organelles, identifying polarity cues and identifying the molecular drivers of ectocytosis. We also use chimeric antigen receptor (CAR) T cells to ask why these cells are less effective killers than native CTLs and how the underlying cell biology differs.

Research at a Glance

Publications Timeline

A big-picture view of Gillian Griffiths's research output by year.
146Publications
15,421Citations

Publications

2025

2024

2023

2022

Get In Touch

Administrative Support

Locations

  • Boyer Center for Molecular Medicine

    Academic Office

    295 Congress Avenue, Rm 236E

    New Haven, CT 06510

    Chair's Office

    203.737.1257
  • Boyer Center for Molecular Medicine

    Lab

    295 Congress Avenue, Rm 231-233

    New Haven, CT 06510

Events